Results for "vision problems"
Conditions Encyclopedia Entry 1775591525
** **Mitochondrial Myopathies** are a group of rare genetic disorders caused by mutations in the mitochondrial DNA, leading to muscle weakness, fatigue, and other systemic symptoms. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a heterogeneous group of disorders characterized by the impaired function of the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA (mtDNA), which is inherited from one's mother. Mitochondrial myopathies affect various systems in the body, including the muscles, nervous system, and other organs. The symptoms of MM can vary widely, depending on the specific mutation and the affected individual. Mitochondrial myopathies are relatively rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. However, the prevalence of MM is likely underestimated due to the lack of awareness and the complexity of diagnosing these disorders. The symptoms of MM can be subtle and may not become apparent until later in life, making diagnosis challenging. ### History/Background The first reported case of mitochondrial myopathy was in 1962, when a British neurologist, Dr. Keith Baraitser, described a patient with a rare disorder characterized by muscle weakness, fatigue, and other systemic symptoms. Since then, numerous cases have been reported, and the understanding of MM has evolved significantly. In the 1980s, the discovery of the mitochondrial DNA and the development of techniques to analyze mtDNA mutations led to a better understanding of the genetic basis of MM. ### Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which can occur in any of the 37 genes that code for proteins involved in energy production. The most common mutations associated with MM include: * **MELAS syndrome**: a condition characterized by muscle weakness, seizures, and other systemic symptoms. * **MERRF syndrome**: a condition characterized by muscle weakness, ataxia, and other systemic symptoms. * **KSS syndrome**: a condition characterized by muscle weakness, hearing loss, and other systemic symptoms. The symptoms of MM can vary widely, depending on the specific mutation and the affected individual. Common symptoms include: * **Muscle weakness**: weakness and wasting of muscles, particularly in the face, arms, and legs. * **Fatigue**: persistent and debilitating fatigue, even after rest. * **Headaches**: frequent and severe headaches. * **Seizures**: seizures and other neurological symptoms. * **Vision problems**: blurred vision, double vision, and other vision problems. ### Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining overall health. The symptoms of MM can have a profound impact on an individual's quality of life, making it essential to diagnose and manage these disorders effectively. While there is no cure for MM, various treatments can help manage symptoms and improve quality of life. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1962 (first reported case) - Location: Worldwide - Known For: Rare genetic disorders caused by mitochondrial DNA mutations **TAGS:** Mitochondrial myopathies, genetic disorders, muscle weakness, fatigue, seizures, headaches, vision problems, mitochondrial DNA, mtDNA mutations.
Health & MedicineConditions Encyclopedia Entry 1775523183
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which leads to impaired energy production and cellular dysfunction. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms and severity of the disorders can vary widely among individuals, and they often manifest in childhood or adolescence. Mitochondrial myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, and pain. Some individuals may experience seizures, loss of coordination, and vision problems. In severe cases, the disorders can lead to life-threatening complications, such as respiratory failure and cardiac arrest. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. ## History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with muscle weakness and other symptoms that were linked to mitochondrial dysfunction. Since then, numerous studies have been conducted to understand the genetic and molecular mechanisms underlying these disorders. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. Since then, over 1,000 different mutations have been identified, and the disorders have been classified into several subtypes. ## Key Information Mitochondrial myopathies are caused by mutations in the mitochondrial DNA, which affects the production of energy in the form of ATP. The disorders can be classified into several subtypes, including: - **NARP syndrome** (Neuropathy, Ataxia, and Retinitis Pigmentosa): a rare disorder characterized by muscle weakness, vision loss, and ataxia. - **MELAS syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes): a disorder characterized by muscle weakness, seizures, and stroke-like episodes. - **Kearns-Sayre syndrome**: a disorder characterized by muscle weakness, vision loss, and cardiac problems. ## Significance Mitochondrial myopathies are significant because they highlight the importance of mitochondrial function in maintaining cellular health. The disorders also underscore the importance of genetic testing and counseling for individuals and families affected by these conditions. Furthermore, research on mitochondrial myopathies has led to a greater understanding of the molecular mechanisms underlying these disorders and has paved the way for the development of new treatments. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic Disorders - **Date:** First reported cases in the 1960s - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting mitochondrial function **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, energy production, muscle weakness, fatigue, seizures, vision problems, NARP syndrome, MELAS syndrome, Kearns-Sayre syndrome, genetic testing, counseling. **When to Seek Professional Care:** If you or a family member is experiencing symptoms of mitochondrial myopathies, seek medical attention from a qualified healthcare professional. Early diagnosis and treatment can significantly improve outcomes and quality of life.
Health & MedicineConditions Encyclopedia Entry 1777230006
Mitochondrial myopathies are a group of rare genetic disorders affecting the mitochondria, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1775388487
** **Mitochondrial Myopathies** are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells, leading to muscle weakness, fatigue, and other systemic symptoms. ## Overview Mitochondrial myopathies are a diverse group of disorders caused by mutations in the mitochondrial DNA (mtDNA) or nuclear DNA (nDNA) that affect the function of the mitochondria. Mitochondria are the powerhouses of cells, responsible for generating energy in the form of ATP (adenosine triphosphate). In individuals with mitochondrial myopathies, the mitochondria are unable to produce sufficient energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies can affect any part of the body, but they most commonly affect the muscles, particularly those involved in movement, such as the skeletal muscles. The symptoms of mitochondrial myopathies can vary widely, depending on the specific disorder and the affected individual. Some common symptoms include muscle weakness, fatigue, exercise intolerance, and muscle cramps. Other symptoms may include vision problems, hearing loss, seizures, and developmental delays. ## History/Background Mitochondrial myopathies were first described in the 1960s, when researchers began to understand the role of mitochondria in energy production. Since then, numerous studies have been conducted to identify the genetic causes of these disorders. In the 1980s, the first mitochondrial DNA mutations were identified, and since then, many more have been discovered. Today, there are over 150 known mitochondrial DNA mutations associated with mitochondrial myopathies. ## Key Information Mitochondrial myopathies are caused by mutations in either the mitochondrial DNA or nuclear DNA. Mitochondrial DNA mutations are inherited in a maternal lineage, meaning that they are passed from mother to child. Nuclear DNA mutations, on the other hand, can be inherited from either parent. The most common mitochondrial DNA mutations associated with mitochondrial myopathies include the MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) mutation, the MERRF (myoclonus epilepsy with ragged-red fibers) mutation, and the NARP (neuropathy, ataxia, and retinitis pigmentosa) mutation. Diagnosing mitochondrial myopathies can be challenging, as the symptoms can be nonspecific and similar to those of other disorders. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. Treatment for mitochondrial myopathies is largely supportive, focusing on managing symptoms and improving quality of life. Some individuals may benefit from dietary changes, such as a high-fat diet, or supplements, such as coenzyme Q10. ## Significance Mitochondrial myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. These disorders can have a profound impact on an individual's quality of life, causing significant disability and reducing life expectancy. However, advances in genetic testing and diagnosis have improved our understanding of these disorders, allowing for more effective management and treatment. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first described) - **Location:** Global - **Known For:** Rare genetic disorders affecting energy production in cells TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial DNA, nuclear DNA, muscle weakness, fatigue, exercise intolerance, muscle cramps, vision problems, hearing loss, seizures, developmental delays, MELAS, MERRF, NARP, coenzyme Q10, high-fat diet.
Health & MedicineConditions Encyclopedia Entry 1778661024
Mitochondrial myopathies are a group of rare genetic disorders characterized by the abnormal functioning of mitochondria, leading to muscle weakness, fatigue, and other systemic symptoms.
Health & MedicineConditions Encyclopedia Entry 1780308965
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are characterized by the accumulation of mutations in the mitochondrial DNA, leading to impaired energy production and cellular dysfunction. Mitochondrial myopathies can affect various tissues and organs, including muscles, nerves, and the brain. The symptoms and severity of the disorder vary widely among individuals, depending on the specific mutation and the extent of mitochondrial damage. Mitochondrial myopathies are often inherited in an **autosomal dominant** or **maternal inheritance** pattern, meaning that a single copy of the mutated gene is sufficient to cause the disorder. In some cases, the disorder can also be caused by **de novo** mutations, which occur spontaneously during fertilization or early embryonic development. The diagnosis of mitochondrial myopathies is often challenging, as the symptoms can be nonspecific and similar to those of other conditions. A definitive diagnosis typically requires a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to recognize the importance of mitochondrial function in energy production. In the 1980s, the discovery of mitochondrial DNA mutations led to a better understanding of the genetic basis of these disorders. Since then, numerous studies have shed light on the molecular mechanisms underlying mitochondrial myopathies and the development of new diagnostic and therapeutic strategies. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * **Muscle weakness** and **fatigue**, particularly in the muscles of the face, arms, and legs * **Muscle pain** and **cramping** * **Numbness** and **tingling** in the hands and feet * **Vision problems**, including **blindness** and **double vision** * **Cognitive impairment** and **dementia** * **Cardiac problems**, including **heart failure** and **arrhythmias** The diagnosis of mitochondrial myopathies typically involves a combination of: * **Genetic testing**, including **DNA sequencing** and **mutation analysis** * **Muscle biopsy**, which can help identify mitochondrial damage and dysfunction * **Imaging studies**, such as **MRI** and **CT scans**, to evaluate muscle and nerve damage * **Electrophysiological studies**, such as **EMG** and **nerve conduction studies**, to assess muscle and nerve function ## Significance Mitochondrial myopathies are a significant public health concern, affecting approximately 1 in 5,000 people worldwide. The disorders are often associated with a poor prognosis, with many individuals experiencing significant disability and a reduced life expectancy. However, advances in genetic testing and diagnostic techniques have improved our ability to diagnose and manage these disorders. Researchers are also exploring new therapeutic strategies, including **gene therapy** and **mitochondrial-targeted antioxidants**, which may offer hope for the treatment and prevention of mitochondrial myopathies. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first descriptions) - Location: Worldwide - Known For: Rare genetic disorders affecting mitochondrial function **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, autosomal dominant, maternal inheritance, de novo mutations, muscle weakness, fatigue, muscle pain, numbness, tingling, vision problems, cognitive impairment, cardiac problems, genetic testing, muscle biopsy, imaging studies, electrophysiological studies.
Health & MedicineConditions Encyclopedia Entry 1778766366
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which is responsible for producing energy for the cell. As a result, the muscles, particularly those involved in movement, become weak and degenerate. MMs are a type of mitochondrial disease, which is a broad category of disorders that affect the mitochondria. There are over 200 known mitochondrial diseases, with MMs being one of the most common forms. Mitochondrial Myopathies are characterized by a range of symptoms, including muscle weakness, fatigue, and pain. The muscles most commonly affected are those of the face, neck, and limbs. Some people with MMs may also experience vision problems, hearing loss, and gastrointestinal issues. The symptoms of MMs can vary widely from person to person, and some individuals may not experience any symptoms at all. ## History/Background The first reported cases of MMs date back to the 1960s, when researchers began to identify the genetic mutations responsible for the disorders. Since then, numerous studies have been conducted to better understand the causes and effects of MMs. In the 1980s, the first genetic tests were developed to diagnose MMs, which has led to a better understanding of the disorders and their impact on individuals and families. ## Key Information Mitochondrial Myopathies are caused by mutations in the mitochondrial DNA, which is inherited from one's mother. The most common mutation associated with MMs is the MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) mutation. Other mutations, such as the MERRF (Myoclonus Epilepsy with Ragged-Red Fibers) mutation, are also associated with MMs. There are several types of MMs, including: * **MELAS syndrome**: characterized by muscle weakness, seizures, and vision problems * **MERRF syndrome**: characterized by muscle weakness, seizures, and hearing loss * **Kearns-Sayre syndrome**: characterized by muscle weakness, vision problems, and heart disease * **NARP syndrome**: characterized by muscle weakness, vision problems, and nerve damage ## Significance Mitochondrial Myopathies are a significant public health concern, as they can have a profound impact on an individual's quality of life. The disorders can lead to significant disability and even death, particularly if left untreated. However, with early diagnosis and treatment, individuals with MMs can manage their symptoms and lead active and fulfilling lives. Research into MMs has also led to a greater understanding of the role of mitochondria in human health and disease. This knowledge has implications for the development of new treatments for a range of conditions, including cancer, neurodegenerative diseases, and metabolic disorders. **INFOBOX:** - Name: Mitochondrial Myopathies - Type: Genetic disorder - Date: 1960s (first reported cases) - Location: Global - Known For: Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial disease, genetic disorder, muscle weakness, fatigue, pain, vision problems, hearing loss, gastrointestinal issues, MELAS syndrome, MERRF syndrome, Kearns-Sayre syndrome, NARP syndrome. **Important Note:** If you or a family member is experiencing symptoms of Mitochondrial Myopathies, seek medical attention from a qualified healthcare professional. Early diagnosis and treatment can significantly improve outcomes and quality of life.
Health & MedicineConditions Encyclopedia Entry 1780323144
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which are responsible for producing energy for the cell. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of mitochondrial myopathies can vary widely, but often include muscle weakness, fatigue, and other systemic problems. Mitochondrial myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be caused by spontaneous mutations or by exposure to certain environmental toxins. The diagnosis of mitochondrial myopathies can be challenging, as the symptoms can be similar to those of other conditions. A diagnosis is typically made through a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first descriptions of mitochondrial myopathies date back to the 1960s, when researchers began to identify the role of mitochondria in energy production. However, it wasn't until the 1980s that the genetic basis of these disorders was understood. Since then, numerous studies have been conducted to better understand the causes and consequences of mitochondrial myopathies. Key milestones in the history of mitochondrial myopathies include: * 1960s: The first descriptions of mitochondrial myopathies are published. * 1980s: The genetic basis of mitochondrial myopathies is identified. * 1990s: The first genetic tests for mitochondrial myopathies are developed. * 2000s: The first treatments for mitochondrial myopathies are introduced. ## Key Information Mitochondrial myopathies are characterized by a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Numbness and tingling in the hands and feet * Vision problems * Hearing loss * Cognitive impairment The key features of mitochondrial myopathies include: * **Mitochondrial dysfunction**: The mitochondria are unable to produce energy for the cell, leading to a range of systemic problems. * **Genetic inheritance**: Mitochondrial myopathies are often inherited in an autosomal dominant pattern. * **Variable symptoms**: The symptoms of mitochondrial myopathies can vary widely from person to person. ## Significance Mitochondrial myopathies are significant because they: * **Highlight the importance of mitochondrial function**: Mitochondrial myopathies demonstrate the critical role of mitochondria in energy production and overall health. * **Provide insights into the genetic basis of disease**: The study of mitochondrial myopathies has shed light on the genetic mechanisms underlying these disorders. * **Offer opportunities for treatment and management**: While there is currently no cure for mitochondrial myopathies, various treatments and management strategies can help alleviate symptoms and improve quality of life. INFOBOX: - Name: Mitochondrial Myopathies - Type: Rare genetic disorders - Date: 1960s (first descriptions) - Location: Global - Known For: Rare genetic disorders affecting mitochondrial function TAGS: Mitochondrial myopathies, genetic disorders, mitochondrial dysfunction, rare diseases, muscle weakness, fatigue, exercise intolerance, numbness, tingling, vision problems, hearing loss, cognitive impairment.
Health & MedicineConditions Encyclopedia Entry 1782350524
** This encyclopedia entry is about **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. **CONTENT:** ### Overview Mitochondrial Myopathies (MM) are a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, leading to impaired energy production and cellular dysfunction. Mitochondrial myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms and severity of MM vary widely among individuals, making diagnosis and treatment challenging. Mitochondrial myopathies are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. In some cases, the mutations can occur spontaneously, without a family history. The disorders are typically characterized by progressive muscle weakness, fatigue, and other systemic symptoms. ### History/Background The first reported cases of mitochondrial myopathies date back to the 1960s, when researchers identified a group of patients with unusual muscle disorders. Over the years, advances in genetic testing and molecular biology have led to a better understanding of the underlying causes of MM. In 1988, the first mitochondrial DNA mutation was identified as the cause of a mitochondrial myopathy. Since then, numerous mutations have been identified, and the classification of MM has been refined. ### Key Information Mitochondrial myopathies are a heterogeneous group of disorders, and the specific symptoms and characteristics can vary widely. Some common features include: * **Muscle weakness**: Progressive muscle weakness, particularly in the muscles of the face, neck, and limbs. * **Fatigue**: Severe fatigue, even after rest. * **Neurological symptoms**: Numbness, tingling, and weakness in the hands and feet. * **Vision problems**: Blurred vision, double vision, and loss of vision. * **Cardiac problems**: Abnormal heart rhythms and heart failure. * **Gastrointestinal problems**: Nausea, vomiting, and diarrhea. The diagnosis of MM typically involves a combination of clinical evaluation, genetic testing, and muscle biopsy. Genetic testing can identify the specific mutation responsible for the disorder, while muscle biopsy can provide information on the extent of muscle damage. ### Significance Mitochondrial myopathies are rare disorders, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. However, the impact of MM on individuals and families can be significant. The disorders can lead to severe disability, reduced life expectancy, and significant economic burden. Advances in genetic testing and molecular biology have improved our understanding of MM and have led to the development of targeted therapies. However, more research is needed to develop effective treatments and improve the quality of life for individuals with MM. **INFOBOX:** - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first reported cases) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria **TAGS:** Mitochondrial myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, neurological symptoms, vision problems, cardiac problems, gastrointestinal problems.
Health & MedicineConditions Encyclopedia Entry 1782206045
** This article provides an in-depth look at **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells. ## Overview Mitochondrial Myopathies are a group of rare genetic disorders that affect the mitochondria, the energy-producing structures within cells. These disorders are caused by mutations in the mitochondrial DNA, which leads to impaired energy production and subsequent damage to muscle tissue. Mitochondrial Myopathies can affect various parts of the body, including the muscles, nervous system, and other organs. The symptoms of Mitochondrial Myopathies can vary widely, but often include muscle weakness, fatigue, and pain. Mitochondrial Myopathies are often inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition. However, some cases may be caused by spontaneous mutations or other factors. The diagnosis of Mitochondrial Myopathies typically involves a combination of clinical evaluation, genetic testing, and muscle biopsy. ## History/Background The first reported case of Mitochondrial Myopathies dates back to 1962, when a British physician named **Morgan Hughes** described a patient with a rare muscle disorder. However, it wasn't until the 1980s that the genetic basis of Mitochondrial Myopathies was discovered. In 1988, a team of researchers led by **Doug Wallace** identified the first mitochondrial DNA mutation associated with the condition. Since then, numerous studies have shed light on the genetic and molecular mechanisms underlying Mitochondrial Myopathies. In 1991, the first mitochondrial DNA sequence was published, providing valuable insights into the structure and function of mitochondrial DNA. Today, Mitochondrial Myopathies are recognized as a distinct group of disorders, with over 150 different mutations identified. ## Key Information Mitochondrial Myopathies are characterized by a range of symptoms, including: * Muscle weakness and wasting * Fatigue and exercise intolerance * Muscle pain and cramping * Numbness and tingling in the hands and feet * Vision problems and hearing loss * Cognitive impairment and seizures The diagnosis of Mitochondrial Myopathies typically involves a combination of: * Clinical evaluation and medical history * Genetic testing, including mitochondrial DNA sequencing * Muscle biopsy and histopathological examination * Electromyography (EMG) and nerve conduction studies There is currently no cure for Mitochondrial Myopathies, but various treatments can help manage symptoms and slow disease progression. These may include: * Exercise therapy and physical rehabilitation * Medications to alleviate muscle pain and weakness * Nutritional supplements and dietary modifications * Assistive devices and technology to aid mobility and daily activities ## Significance Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 people worldwide. Despite their rarity, these disorders have a profound impact on the lives of those affected, causing significant disability and distress. Research into Mitochondrial Myopathies has also led to a greater understanding of the biology of mitochondria and their role in human disease. This knowledge has far-reaching implications for the diagnosis and treatment of a range of conditions, including cancer, neurodegenerative disorders, and metabolic diseases. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1962 (first reported case) - **Location:** Worldwide - **Known For:** Rare genetic disorders affecting the mitochondria TAGS: Mitochondrial Myopathies, genetic disorders, mitochondrial DNA, muscle weakness, fatigue, exercise intolerance, muscle pain, numbness, tingling, vision problems, hearing loss, cognitive impairment, seizures, exercise therapy, physical rehabilitation, medications, nutritional supplements, dietary modifications, assistive devices, technology.